期刊文献+

2015年北京协和医院细菌耐药性监测 被引量:14

Surveillance of Antimicrobial Resistance in Peking Union Medical College Hospital in 2015
下载PDF
导出
摘要 目的了解2015年北京协和医院临床分离细菌对抗菌药物的耐药性。方法收集2015年1月1日至12月31日北京协和医院临床分离的5746株非重复细菌,采用纸片扩散法或自动化仪器法进行药敏试验,按美国临床实验室标准化协会2015年版标准判读药敏结果,采用WHONET 5.6软件进行数据分析。结果 5746株非重复细菌中,10种最常见细菌分别为:大肠埃希菌(19.4%)、铜绿假单胞菌(11.3%)、肺炎克雷伯菌(10.9%)、金黄色葡萄球菌(9.8%)、鲍曼不动杆菌(9.6%)、粪肠球菌(6.5%)、B群链球菌(5.1%)、屎肠球菌(4.6%)、凝固酶阴性葡萄球菌(2.7%)、阴沟肠杆菌(2.5%)。其中革兰阴性菌占67.5%,革兰阳性菌占32.5%。耐甲氧西林金黄色葡萄球菌(methicillin-resistant Staphylococcus aureus,MRSA)和耐甲氧西林凝固酶阴性葡萄球菌(methicillin-resistant coagulase-negative Staphylococcus,MRCNS)的检出率分别为22.9%和77.6%。MRSA和MRCNS菌株对β内酰胺类和其他抗菌药物的耐药率明显高于甲氧西林敏感金黄色葡萄球菌(methicillin-susceptible Staphylococcus aureus,MSSA)和甲氧西林敏感凝固酶阴性葡萄球菌(methicillin-susceptible coagulase-negative Staphylococcus,MSCNS)菌株。仍有88.8%的MRSA对磺胺甲噁唑-甲氧苄啶敏感。MRCNS中有81.7%的菌株对利福平敏感。未发现对万古霉素、替考拉宁和利奈唑胺耐药的葡萄球菌。粪肠球菌对大多数抗菌药物(除氯霉素外)的耐药率要明显低于屎肠球菌。两者中均有少数万古霉素耐药株,未发现对利奈唑胺耐药的肠球菌。β溶血链球菌对青霉素的敏感率为90.8%。产超广谱β-内酰胺酶的大肠埃希菌、克雷伯菌属(肺炎克雷伯菌和产酸克雷伯菌)和奇异变形杆菌的检出率分别为52.3%(582/1112)、28.9%(200/692)和26.2%(27/103)。肠杆菌科细菌对碳青霉烯类仍高度敏感,总耐药率≤4.3%。泛耐药肺炎克雷伯菌的检出率为3.0%(19/630)。鲍曼不动杆菌对亚胺培南和美 Objective To investigate the antimicrobial resistance of clinical bacterial isolates in Peking Union Medical College Hospital (PUMCH) in 2015. Methods A total of 5746 non-duplicate clinical isolates from January 1 to December 31 2015 were collected. Disc diffusion test ( Kirby-Bauer method) and automated systems were employed to detect the antimicrobial resistance. The data were analyzed by WHONET 5. 6 software according to 2015 edition of antimicrobial susceptibility testing standards issued by The Clinical and Laboratory Standards Institute (CLSI) of the United States. Results Of the 5746 clinical isolates, the 10 most common bacteria were: Escherichia coli ( 19. 4 % ) , Pseudomonas aeruginosa (11.3 % ) , Klebsiella pneumoniae (10. 9% ) , Staphylococcus aureus (9. 8 % ) , Acinetobacter baumannii (9.6% ) , Enterococcus faecalis (6. 5 % ), Streptococcus agalactiae (5. 1% ) , Enterococcus faecium (4. 6 % ) , coagulase-negative Staphylococcus (2.1% ), and Enterobacter cloacae ( 2. 5% ). Gram-negative bacilli and gram-positive cocci accounted for 67. 5 % and 32. 5% , respectively. Among Staphylococcus aureus and Staphylococcus isolates, methicillin-resistant Staphyloccus aureus (MRSA) and methicillin-resistant coagulase-negative (MRCNS) accounted for 22. 9 %and 77. 6% , respectively. The resistance rates of MRSA and MRCNS strains to ( B-lactams and other antimicrobial agents were much higher than those in methicillin-susceptible Staphylococcus aureus (MSSA) and methicillin- susceptible coagulase-negatible Staphylococcus (MSCNS) strains. 88. 8 % of MRSA strains were still susceptible to trimethoprim- sulfamethoxazole, while 81. 7 % of MRCNS strains were susceptible to rifampin. No staphylococcal strain resistant to vancomycin, teicoplanin, or linezolid was detected. The resistance rate of E. Faecalis strains to most of the antimicrobial agents tested ( except Chloramphen
出处 《协和医学杂志》 2016年第5期334-341,共8页 Medical Journal of Peking Union Medical College Hospital
关键词 细菌耐药性监测 抗菌药物 广泛耐药菌 药敏试验 antimicrobial resistance surveillance antimicrobial agents extensively drug-resistant bacteria antimicrobial sus-ceptibility testing
  • 相关文献

参考文献8

  • 1Clinical and Laboratory Standards Institute. Performance standardsfor antimicrobial susceptibility testing. M100-S24 [S].Wayne, PA: CLSI, 2014. 被引量:1
  • 2Jones RN, Ferraro MJ, Reller LB, et al. Multicenter studies oftigecycline disk diffusion susceptibility results for Acinetobacterspp. [J]. J Clin Microbiol, 2007, 45: 227-230. 被引量:1
  • 3张小江,张辉,窦红涛,朱任媛,谢秀丽,王澎,赵颖,宋红梅,王贺,王瑶,杨启文,孙宏莉,陈雨,徐英春.2012年北京协和医院细菌耐药性监测[J].中国感染与化疗杂志,2014,14(2):104-111. 被引量:25
  • 4胡付品,朱德妹,汪复,蒋晓飞,徐英春,张小江,张朝霞,季萍,谢轶,康梅,王传清,王爱敏,徐元宏,沈继录,孙自镛,陈中举,倪语星,孙景勇,褚云卓,田素飞,胡志东,李金,俞云松,林洁,单斌,杜艳,韩艳秋,郭素芳,魏莲花,吴玲,张泓,孔菁,胡云建,艾效曼,卓超,苏丹虹.2014年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2015,15(5):401-410. 被引量:727
  • 5Parisi SG, Bartolini A, Santacatterina E , et al. Prevalence ofKlebsiella pneumoniae strains producing carbapenemases andincrease of resistance to colistin in an Italian teaching hospitalfrom January 2012 To December 2014 [J]. BMC Infec Dis,2015, 15: 244-253. 被引量:1
  • 6Yamamoto M, Pop-Vicas AE. Treatment for infections withcarbapenem resistant Enterobacteriaceae : what options do westill have- [J]. Critical Care, 2014, 18: 229-236. 被引量:1
  • 7Paul M, Carmeli Y, Durante-Mangoni E, et al. Combinationtherapy for carbapenem-resistant Gram-negative bacteria [J] . JAntimicrob Chemother, 2014, 69: 2305-2309. 被引量:1
  • 8Tzouvelekis LS, Markogiannakis A, Piperaki E , et al. Treatinginfections caused by carbapenemase-producing Enterobacteriaceae[J]. Clin Microbiol Infect, 2014, 20: 862-872. 被引量:1

二级参考文献15

  • 1Clinical and Laboratory Standards Institute (CLSI). Perform- ance standards for antimicrobial susceptibility testing [S]. M100-S22 2012. 被引量:1
  • 2Neuner EA, Sekeres J, Hall GS, et al. Experience with fos- fomycin for treatment of urinary tract Infections due to multi drug-resistant organisms[J]. Antimicrob Agents Chemother, 2012, 56(11): 5744-5748. 被引量:1
  • 3Falagas ME, Karageorgopoulos DE. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram negative bacilli: need for international harmonization in terminology[J]. Clin Infect Dis, 2008, 46(7): 1121-1122. 被引量:1
  • 4Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twenty fourth informational supplement, 2014, M100-S24. 被引量:1
  • 5Hu F, Chen S, Xu X, et al. Emergence of carbapenem- resistant Enterobacteriaceae clinical isolates from a teaching hospital in Shanghai, China[J]. J Med Microbiol, 2012, 61 (Pt 1): 132-136. 被引量:1
  • 6Van Duin D, Kaye KS, Neuner EA, et al. Carbapenem-resistant Enterol2acteriaceae= a review of treatment and outcomes [J]. Diagn Microbiol Infect Dis, 2013, 75(2): 115-120. 被引量:1
  • 7Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase- producing Klebsiella tmeumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems[J]. Antimicrob Agents Chemother, 2014, 58 (4): 2322-2328. 被引量:1
  • 8Tascini C, Jagliaferri E, Giani T, et al. Synergistic activity of colistin plus rifampin against colistin resistant KPC producing Klebsiella pneumoniae [J]. Antimicrob Agents Chemother, 2013, 57(8): 3990-3993. 被引量:1
  • 9Tzouvelekis LS, Markogiannakis A, Psichogiou M, et al. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions [J]. Clin Microbiol Rev, 2012, 25(4): 682-707. 被引量:1
  • 10王辉,倪语星,陈民钧,胡必杰,王明贵,陈佰义,胡继红,胡云建.新型甘氨酰环素类抗菌药物替加环素的体外药敏试验操作规程[J].中华检验医学杂志,2009,32(11):1208-1213. 被引量:65

共引文献748

同被引文献97

引证文献14

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部